118 related articles for article (PubMed ID: 11214938)
1. A single amino acid alteration in murine PrP dramatically alters TSE incubation time.
Manson JC; Barron R; Jamieson E; Baybutt H; Tuzi N; McConnell I; Melton D; Hope J; Bostock C
Arch Virol Suppl; 2000; (16):95-102. PubMed ID: 11214938
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.
Manson JC; Jamieson E; Baybutt H; Tuzi NL; Barron R; McConnell I; Somerville R; Ironside J; Will R; Sy MS; Melton DW; Hope J; Bostock C
EMBO J; 1999 Dec; 18(23):6855-64. PubMed ID: 10581259
[TBL] [Abstract][Full Text] [Related]
3. A gene-targeted mouse model of P102L Gerstmann-Sträussler-Scheinker syndrome.
Barron RM; Manson JC
Clin Lab Med; 2003 Mar; 23(1):161-73. PubMed ID: 12733430
[TBL] [Abstract][Full Text] [Related]
4. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.
Asante EA; Grimshaw A; Smidak M; Jakubcova T; Tomlinson A; Jeelani A; Hamdan S; Powell C; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Collinge J
PLoS Pathog; 2015 Jul; 11(7):e1004953. PubMed ID: 26135918
[TBL] [Abstract][Full Text] [Related]
5. Transmission of murine scrapie to P101L transgenic mice.
Barron RM; Thomson V; King D; Shaw J; Melton DW; Manson JC
J Gen Virol; 2003 Nov; 84(Pt 11):3165-3172. PubMed ID: 14573822
[TBL] [Abstract][Full Text] [Related]
6. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.
Barron RM; Thomson V; Jamieson E; Melton DW; Ironside J; Will R; Manson JC
EMBO J; 2001 Sep; 20(18):5070-8. PubMed ID: 11566872
[TBL] [Abstract][Full Text] [Related]
7. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
[TBL] [Abstract][Full Text] [Related]
8. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
Piccardo P; King D; Telling G; Manson JC; Barron RM
J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
[TBL] [Abstract][Full Text] [Related]
10. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
11. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.
Telling GC; Haga T; Torchia M; Tremblay P; DeArmond SJ; Prusiner SB
Genes Dev; 1996 Jul; 10(14):1736-50. PubMed ID: 8698234
[TBL] [Abstract][Full Text] [Related]
12. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
13. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.
Jeffrey M; McGovern G; Chambers EV; King D; González L; Manson JC; Ghetti B; Piccardo P; Barron RM
Brain Pathol; 2012 Jan; 22(1):58-66. PubMed ID: 21645162
[TBL] [Abstract][Full Text] [Related]
15. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
[TBL] [Abstract][Full Text] [Related]
16. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
17. The role of host PrP in Transmissible Spongiform Encephalopathies.
Cancellotti E; Barron RM; Bishop MT; Hart P; Wiseman F; Manson JC
Biochim Biophys Acta; 2007 Jun; 1772(6):673-80. PubMed ID: 17150338
[TBL] [Abstract][Full Text] [Related]
18. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
19. Towards authentic transgenic mouse models of heritable PrP prion diseases.
Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
[TBL] [Abstract][Full Text] [Related]
20. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
